G Square Healthcare Private Equity has acquired a majority stake in G21 S.r.l., a leading Italian biomaterial solutions provider for orthopedic and spine applications, to accelerate its growth and international expansion.

Target Company Overview

G21 S.r.l. is a prominent Italian company specializing in the development, manufacturing, and distribution of proprietary biomaterial solutions for orthopedic and spine applications. Established in 2009 and located in San Possidonio, Modena, G21 has gained recognition for its innovative approaches in creating bone cements, modular spacers for shoulder, knee, and hip applications, as well as minimally invasive surgical solutions for kyphoplasty and vertebroplasty. Over the past decade, the company has built a robust reputation and achieved significant growth in both Italy and international markets, currently serving surgeons and healthcare providers across 55 countries.

G21’s dedication to innovation is complemented by its solid research and development capabilities, which are evident in its comprehensive product offerings. The company is committed to enhancing surgical precision and improving patient outcomes through its advanced biomaterial technologies. Furthermore, G21 has established valuable partnerships with healthcare professionals and distributors, fostering a strong global presence.

Industry Overview in Italy

The Italian medical technology industry is recognized as one of the largest and most advanced in Europe. With a keen emphasis on innovation and quality, the sector is home to numerous companies focused on medical devices and technol